What the research shows
The supplier’s description specifies a copper-bound peptide, two shorter chains and a 43-amino-acid component labeled TB-500. It documents one formulation. It reports no controlled human outcome for that mixture. Check the supplier’s composition statement.
Dalmasso and colleagues measured inflammatory signals in cells exposed to KPV and studied KPV in mice. Their experiments used KPV on its own, so the results cannot establish an effect of KLOW. See which material the KPV experiment tested.
Documented formats
The cited formulation is a freeze-dried mixture in one vial. A paper on a single constituent describes a different test material.
Testing and purity
Request an identity result and a measured amount for each component in the same lot. For TB-500, match the full sequence and its length to the formulation under discussion.
How to read a batch reportQuestions about KLOW
Can one purity percentage verify four ingredients?
A combined number leaves the identity and amount of each constituent unresolved. Look for four separate assignments and the method behind them.
What would a study of the blend need to specify?
Look for all four constituents, their proportions, the batch used and a comparison group. To test whether mixing them adds an effect, the study also needs suitable individual-ingredient comparisons.